BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27460089)

  • 21. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
    Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia.
    Bronzini I; Aresu L; Paganin M; Marchioretto L; Comazzi S; Cian F; Riondato F; Marconato L; Martini V; Te Kronnie G
    Vet Comp Oncol; 2017 Sep; 15(3):910-918. PubMed ID: 27098563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations.
    Thol F; Kölking B; Damm F; Reinhardt K; Klusmann JH; Reinhardt D; von Neuhoff N; Brugman MH; Schlegelberger B; Suerbaum S; Krauter J; Ganser A; Heuser M
    Genes Chromosomes Cancer; 2012 Jul; 51(7):689-95. PubMed ID: 22454318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
    King RL; Bagg A
    Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia.
    Mukda E; Pintaraks K; Sawangpanich R; Wiangnon S; Pakakasama S
    Asian Pac J Cancer Prev; 2011; 12(7):1827-31. PubMed ID: 22126574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
    Alonso CM; Llop M; Sargas C; Pedrola L; Panadero J; Hervás D; Cervera J; Such E; Ibáñez M; Ayala R; Martínez-López J; Onecha E; de Juan I; Palanca S; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Montesinos P; Sanz G; Sanz MA; Barragán E
    J Mol Diagn; 2019 Mar; 21(2):228-240. PubMed ID: 30576870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next generation sequencing of acute myeloid leukemia: influencing prognosis.
    Ilyas AM; Ahmad S; Faheem M; Naseer MI; Kumosani TA; Al-Qahtani MH; Gari M; Ahmed F
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S5. PubMed ID: 25924101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer related gene alterations can be detected with next-generation sequencing analysis of bile in diffusely infiltrating type cholangiocarcinoma.
    Lee CH; Wang HE; Seo SY; Kim SH; Kim IH; Kim SW; Lee ST; Kim DG; Han MK; Lee SO
    Exp Mol Pathol; 2016 Aug; 101(1):150-6. PubMed ID: 27460275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.
    Zuffa E; Franchini E; Papayannidis C; Baldazzi C; Simonetti G; Testoni N; Abbenante MC; Paolini S; Sartor C; Parisi S; Marconi G; Cattina F; Bochicchio MT; Venturi C; Ottaviani E; Cavo M; Martinelli G
    Oncotarget; 2015 Oct; 6(31):31284-94. PubMed ID: 26384303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality.
    Eisfeld AK; Kohlschmidt J; Mrózek K; Volinia S; Blachly JS; Nicolet D; Oakes C; Kroll K; Orwick S; Carroll AJ; Stone RM; Byrd JC; de la Chapelle A; Bloomfield CD
    Cancer Res; 2017 Jan; 77(1):207-218. PubMed ID: 27784745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of next-generation sequencing in acute myeloid leukemia.
    Llop M; Sargas C; Barragán E
    Curr Opin Oncol; 2022 Nov; 34(6):723-728. PubMed ID: 36102349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
    Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L
    Blood; 2015 Jan; 125(4):600-5. PubMed ID: 25499761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing.
    Arindrarto W; Borràs DM; de Groen RAL; van den Berg RR; Locher IJ; van Diessen SAME; van der Holst R; van der Meijden ED; Honders MW; de Leeuw RH; Verlaat W; Jedema I; Kroes WGM; Knijnenburg J; van Wezel T; Vermaat JSP; Valk PJM; Janssen B; de Knijff P; van Bergen CAM; van den Akker EB; Hoen PAC'; Kiełbasa SM; Laros JFJ; Griffioen M; Veelken H
    Leukemia; 2021 Jan; 35(1):47-61. PubMed ID: 32127641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.